A comprehensive study published in Nature Communications elucidates the molecular and clinical features of pulmonary large cell neuroendocrine carcinoma (LCNEC), a rare and aggressive lung cancer subtype. The research advances understanding of LCNEC heterogeneity, supporting improved diagnostic accuracy and personalized treatment strategies. These findings lay foundational groundwork to tackle a malignancy historically characterized by poor prognosis and therapeutic challenges.